Loading
Journal of Allergy and Infectious Diseases
ISSN: 2692-6334
Latest Articles
A real life asthma biologic treatment comparison
Remedios Cárdenas Contreras , Rocío Picos Baliña , Eloísa Rubio Pérez , Stefan Cimbollek , Manuel Prados-Castaño , Joaquin Quiralte Enríquez
Currently, it is estimated that only a small percentage of asthmatic patients do not achieve adequate control of the disease despite maintaining high doses of inhaled corticosteroids and assuming that they have a correct adherence and inhalation technique. In fact, severe asthma currently accounts for 5-10% of all asthma cases and is often driven by type 2 inflammatory mediators.
J Allergy Infect Dis, 2025, Volume 6, Issue 1, p1-7 | DOI: 10.46439/allergy.6.048
The effect of an aerosol of treignac mineral water concentrated by inverse osmosis in vitro on normal bronchial cells and in vivo on normal rabbit lungs
Jean Sainte-Laudy , Boris Melloni , Vincent Gloaguen , Céline Faugeron Girard
Hydrotherapy is a common technique used in thermal centers, primarily for the external treatment of skin pathologies. Various centers specializing in the management of infectious and inflammatory respiratory pathologies use hydrotherapy techniques internally, as well as through nasally, and bronchially
J Allergy Infect Dis, 2025, Volume 6, Issue 1, p8-12 | DOI: 10.46439/allergy.6.049
Innate lymphoid cell development
Mohamed Khosroshahi Leila , Sadeghalvad Mona , Takei Fumio
Innate lymphoid cells (ILCs) are a heterogeneous family of lymphocytes that lack conventional antigen receptors and play roles in tissue homeostasis and immune responses. Based on their transcriptional and functional properties, ILCs are classified into three main groups: group 1 ILCs (ILC1s and NK cells), group 2 ILCs (ILC2s), and group 3 ILCs (ILC3s). The developmental origins of ILCs remain an area of active investigation.
J Allergy Infect Dis, 2025, Volume 6, Issue 1, p13-16 | DOI:
Impact of SARS-CoV-2 vaccinations on pandemic dynamics: Trends in cases, deaths, and fatality risks
Igor Nesteruk
Despite the decrease in COVID-19 testing and reporting new infections, the numbers of new cases and deaths per capita registered in some European countries and USA in September 2024 were higher than endemic limits and exceeded seasonal flu mortality. These facts make the development of new vaccines or the further use of existing ones very urgent.
J Allergy Infect Dis, 2025, Volume 6, Issue 1, p17-24 | DOI: